Stevens E, Feldstein D, Jones S, Twan C, Cui X, Hess R
PLoS One. 2024; 19(6):e0306195.
PMID: 38917147
PMC: 11198751.
DOI: 10.1371/journal.pone.0306195.
Elsafi S, Almutairi S, Alsulaimani M, AlBahrani S, Al-Maqati T, Alanazi W
Infect Drug Resist. 2024; 17:2227-2236.
PMID: 38854778
PMC: 11162212.
DOI: 10.2147/IDR.S460148.
Ciaccio L, Donnan P, Parcell B, Marwick C
BMJ Open. 2024; 14(4):e081930.
PMID: 38643000
PMC: 11033633.
DOI: 10.1136/bmjopen-2023-081930.
Amato H, Loayza F, Salinas L, Paredes D, Garcia D, Sarzosa S
Sci Rep. 2023; 13(1):14854.
PMID: 37684276
PMC: 10491794.
DOI: 10.1038/s41598-023-39532-5.
Alzueta N, Echeverria A, Garcia P, Sanz L, Gil-Setas A, Beristain X
Antibiotics (Basel). 2023; 12(2).
PMID: 36830228
PMC: 9952456.
DOI: 10.3390/antibiotics12020318.
An Improvement in the Antimicrobial Resistance Patterns of Urinary Isolates in the Out-Of-Hospital Setting following Decreased Community Use of Antibiotics during the COVID-19 Pandemic.
Tedeschi S, Sora E, Berlingeri A, Savini D, Rosselli Del Turco E, Viale P
Antibiotics (Basel). 2023; 12(1).
PMID: 36671327
PMC: 9855107.
DOI: 10.3390/antibiotics12010126.
A step forward in antibiotic use and resistance monitoring: a quarterly surveillance system pilot in 11 European Union/European Economic Area countries, September 2017 to May 2020.
Penalva G, Crespo-Robledo P, Molvik M, Lopez-Navas A, Kacelnik O, Cisneros J
Euro Surveill. 2022; 27(46).
PMID: 36398580
PMC: 9673239.
DOI: 10.2807/1560-7917.ES.2022.27.46.2200082.
Sleeping with the enemy: Will the COVID-19 pandemic turn the tide of antimicrobial-resistant infections?.
Laupland K, Collignon P, Schwartz I
J Assoc Med Microbiol Infect Dis Can. 2022; 6(3):177-180.
PMID: 36337755
PMC: 9615466.
DOI: 10.3138/jammi-2021-05-28.
Impact of COVID-19 Lockdown on the Nasopharyngeal Microbiota of Children and Adults Self-Confined at Home.
Rocafort M, Henares D, Brotons P, Launes C, Fernandez de Sevilla M, Fumado V
Viruses. 2022; 14(7).
PMID: 35891502
PMC: 9315980.
DOI: 10.3390/v14071521.
Community antibiotic prescriptions during COVID-19 era: a population-based cohort study among adults.
Gottesman B, Low M, Netzer D, Almog R, Chowers M
Clin Microbiol Infect. 2022; 28(8):1134-1139.
PMID: 35283310
PMC: 8908574.
DOI: 10.1016/j.cmi.2022.02.035.
Antibiotic Use in China's Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018-2020.
Yang Y, Geng X, Liu X, Wen X, Wu R, Cui D
Front Pharmacol. 2022; 13:813213.
PMID: 35237164
PMC: 8882946.
DOI: 10.3389/fphar.2022.813213.
Interrupted Time Series Analysis of Pediatric Infectious Diseases and the Consumption of Antibiotics in an Atlantic European Region during the SARS-CoV-2 Pandemic.
Claveria A, Delgado-Martin M, Goicoechea-Castano A, Iglesias-Moreno J, Garcia-Cendon C, Martin-Miguel M
Antibiotics (Basel). 2022; 11(2).
PMID: 35203866
PMC: 8868325.
DOI: 10.3390/antibiotics11020264.
Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries.
Ceulemans M, Foulon V, Panchaud A, Winterfeld U, Pomar L, Lambelet V
Int J Environ Res Public Health. 2022; 19(3).
PMID: 35162405
PMC: 8835534.
DOI: 10.3390/ijerph19031389.
COVID-19 and Antibiotic Prescribing in Pediatric Primary Care.
Dutcher L, Li Y, Lee G, Grundmeier R, Hamilton K, Gerber J
Pediatrics. 2022; 149(2).
PMID: 35102416
PMC: 9825803.
DOI: 10.1542/peds.2021-053079.
Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 2021.
Guisado-Gil A, Benavente R, Villegas-Portero R, Gil-Navarro M, Valencia R, Penalva G
Clin Microbiol Infect. 2022; 28(6):881.e7-881.e12.
PMID: 35026376
PMC: 8743485.
DOI: 10.1016/j.cmi.2021.12.022.
Impact of the COVID-19 Pandemic on Community Antibiotic Prescribing and Stewardship: A Qualitative Interview Study with General Practitioners in England.
Borek A, Maitland K, Mcleod M, Campbell A, Hayhoe B, Butler C
Antibiotics (Basel). 2021; 10(12).
PMID: 34943743
PMC: 8698307.
DOI: 10.3390/antibiotics10121531.
Medication prescribing in face-to-face versus telehealth consultations during the COVID-19 pandemic in Australian general practice: a retrospective observational study.
Wabe N, Thomas J, Sezgin G, Sheikh M, Gault E, Georgiou A
BJGP Open. 2021; 6(1).
PMID: 34819296
PMC: 8958736.
DOI: 10.3399/BJGPO.2021.0132.
Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020.
Hogberg L, Vlahovic-Palcevski V, Pereira C, Weist K, Monnet D
Euro Surveill. 2021; 26(46).
PMID: 34794534
PMC: 8603403.
DOI: 10.2807/1560-7917.ES.2021.26.46.2101020.
COVID-19: Impact on prescribing and antimicrobial resistance.
Ruiz-Garbajosa P, Canton R
Rev Esp Quimioter. 2021; 34 Suppl 1:63-68.
PMID: 34598431
PMC: 8683018.
DOI: 10.37201/req/s01.19.2021.
Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship.
Gillies M, Burgner D, Ivancic L, Nassar N, Miller J, Sullivan S
Br J Clin Pharmacol. 2021; 88(3):1143-1151.
PMID: 34405427
PMC: 8444718.
DOI: 10.1111/bcp.15000.
